These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10962947)

  • 1. [Symptomatic pseudolithiasis caused by Rocephalin].
    Tuckuviene R; Myrtue GS
    Ugeskr Laeger; 2000 Aug; 162(32):4271-2. PubMed ID: 10962947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pseudolithiasis caused by ceftriaxone in children: a case report].
    Benedetti M; Zanchetta S; Bagnani A; Praderio R; Perbellini S; Melo C
    Pediatr Med Chir; 1995; 17(4):369-71. PubMed ID: 7491336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone-induced symptomatic pseudolithiasis mimicking ICP elevation.
    Evliyaoglu C; Kizartici T; Bademci G; Unal B; Keskil S
    Zentralbl Neurochir; 2005 May; 66(2):92-4. PubMed ID: 15846537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of ceftriaxone-associated gallbladder pseudolithiasis.
    Papadopoulou F; Efremidis S; Karyda S; Badouraki M; Karatza E; Panteliadis C; Malaka K
    Acta Paediatr; 1999 Dec; 88(12):1352-5. PubMed ID: 10626521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary pseudolithiasis in childhood: a case report.
    Herek O; Sarioğlu A; Koçer N; Tiryaki A; Akkemik B
    Eur J Pediatr Surg; 1999 Oct; 9(5):337-9. PubMed ID: 10584197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone-associated biliary pseudolithiasis in children.
    Herek O; Pakdemirli E; Koçer N
    Eur Radiol; 2001; 11(5):902. PubMed ID: 11372630
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors leading to ceftriaxone-associated biliary pseudolithiasis in children.
    Kong MS; Chen CY
    Changgeng Yi Xue Za Zhi; 1996 Mar; 19(1):50-4. PubMed ID: 8935375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone-associated gallbladder pseudolithiasis: report of one case.
    Wen HH; Huang YK; Zheng GL
    Acta Paediatr Taiwan; 2004; 45(5):290-2. PubMed ID: 15868813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone-associated biliary pseudolithiasis in paediatric surgical patients.
    Ceran C; Oztoprak I; Cankorkmaz L; Gumuş C; Yildiz T; Koyluoglu G
    Int J Antimicrob Agents; 2005 Mar; 25(3):256-9. PubMed ID: 15737522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ceftriaxone-induced cholelithiasis].
    Maccherini M; Borlini G; Branchi M; Barbonetti C; Moretti P; Bonora G
    Pediatr Med Chir; 1998; 20(5):341-3. PubMed ID: 10068984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transient biliary lithiasis associated with the use of ceftriaxone].
    Alvarez-Coca González J; Cebrero García M; Vecilla Rivelles MC; Alonso Cristobo M; Torrijos Roman C
    An Esp Pediatr; 2000 Oct; 53(4):366-8. PubMed ID: 11083990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transitory biliary pseudolithiasis appearing quickly after ceftriaxone treatment].
    Chevrel J; Barbier R; Mondeteguy J
    Arch Pediatr; 1999 Mar; 6(3):336. PubMed ID: 10191906
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudolithiasis after recent use of ceftriaxone: an unexpected diagnosis in a child with abdominal pain.
    von Martels JZ; Van de Meeberg EK; Holman M; Ligtenberg JJ; Ter Maaten JC
    Am J Emerg Med; 2013 Aug; 31(8):1294.e5-6. PubMed ID: 23809091
    [No Abstract]   [Full Text] [Related]  

  • 14. Disappearing "gallstones": biliary pseudolithiasis complicating ceftriaxone therapy.
    Kirejczyk WM; Crowe HM; Mackay IM; Quintiliani R; Cronin EB
    AJR Am J Roentgenol; 1992 Aug; 159(2):329-30. PubMed ID: 1632349
    [No Abstract]   [Full Text] [Related]  

  • 15. Ceftriaxone-associated biliary pseudolithiasis in children.
    Biner B; Oner N; Celtik C; Bostancioğlu M; Tunçbilek N; Güzel A; Karasalihoğlu S
    J Clin Ultrasound; 2006 Jun; 34(5):217-22. PubMed ID: 16673364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sonographic demonstration of pseudo-cholelithiasis after ceftriaxone].
    Barzilai M
    Harefuah; 1994 Sep; 127(5-6):163-5, 215. PubMed ID: 7995584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis.
    Murata S; Aomatsu T; Yoden A; Tamai H
    Pediatr Int; 2015 Oct; 57(5):942-6. PubMed ID: 25907455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children.
    Palanduz A; Yalçin I; Tonguç E; Güler N; Oneş U; Salman N; Somer A
    J Clin Ultrasound; 2000 May; 28(4):166-8. PubMed ID: 10751736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of ceftriaxone-associated pseudolithiasis in an adult patient that disappeared after the discontinuation of ceftriaxone].
    Tomoda T; Ueki T; Saito S; Tatsukawa M; Nawa T; Hamamoto H; Endo H; Yabushita K; Shimoe T; Sakaguchi K
    Nihon Shokakibyo Gakkai Zasshi; 2013 Aug; 110(8):1481-6. PubMed ID: 23912008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodialysis as a Risk Factor for Ceftriaxone-Associated Pseudolithiasis in Adults.
    Ubukata M; Ohsawa I; Suzuki H; Asao R; Nakamura Y; Nishida H; Nakamura M; Nitta K; Goto Y; Gotoh H
    Ther Apher Dial; 2020 Aug; 24(4):393-399. PubMed ID: 31626369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.